Studies have shown that neutralizing IL-17 or inhibiting its signaling pathways can reduce the severity of myocarditis and improve cardiac function in animal models (59, 60) In EAM, CD69 negatively regulated cardiac inflammation through control of heart-specific Th17 responses (61) (Figure 1). This evidence concerns the gene CD69 and myocarditis.